Merck CEO talks medicines beyond the company's top cancer drug By: CNBC.com News January 14, 2025 at 18:52 PM EST Merck CEO Rob Davis told CNBC's Jim Cramer that there's more to the pharmaceutical giant than its lucrative cancer drug, Keytruda. Read More >>